BiopharmaceuticalsBiopharmaceuticals

News

Québec International and the people of Quebec City stand in solidarity with the local Muslim community

Press releases - Québec International would like to take this opportunity to express its solidarity with all of Quebec City's Muslim community in the wake of last night's tragic events at the local Islamic cultural centre (Centre culturel islamique de Québec).

Immunovaccine Names Frederic Ors Chief Executive Officer; Andy Sheldon, Medicago CEO, To Join Board of Directors

News - Immunovaccine, a clinical stage vaccine and immunotherapy company, today announced that Frederic Ors has been appointed Chief Executive Officer. He and Andy Sheldon, President and CEO of Medicago, will be nominated to the board of directors at the Company’s AGM, and the Board will recommend their election.

Medicago engaged by the Canadian Government to develop Ebola monoclonal antibodies

News - Medicago, a leading Canadian company in the development and production of plant-based therapeutics and vaccines, has been awarded a contract by the Public Health Agency of Canada (PHAC) to develop two antibodies to fight the Sudan strain of the Ebola virus. Medicago will produce these antibodies at its facility in Quebec City.

Nordic Life Science Pipeline Inc. launches the sales of SQIN™, a high-end ultra moisturizing and repairing cream especially made and designed for people suffering of mobility impairment or paralysis

News - Nordic Life Science Pipeline Inc. («Nordic») is proud to announce the launch of SQIN™ Body and SQIN ™ Hand & Foot, its first two cosmeceutical products to reach market. SQIN™ constitutes a unique line of skin products specifically designed and adapted for persistent and severe chronic dry skin problems found often in people suffering of paralysis or mobility impairment attributed to age, amputation, neurological and musculoskeletal problems or metabolic disorders.

Québec City: A technology revolution serving the needs of health care

News - The technology revolution that has taken hold in Québec City over the past few decades has spawned a number of life sciences success stories, paving the way for the development of a wide array of technologies in numerous fields. The life sciences sector alone employs nearly 6,000 people in Québec City and generates annual sales of over $1 billion, according to figures compiled by Québec International.c

Dr. Gary Kobinger, Ebola scientist who led ZMapp development, to be director of Centre for Research in Infectious Diseases in Quebec City

News - The scientist who led the work to develop the Ebola drug ZMapp is going to be leaving the National Microbiology Laboratory in Winnipeg. Dr. Gary Kobinger is the lab's chief of special pathogens, heading a team that works on some of the world's worst disease threats. Kobinger will be vacating that position next June to become the director of the Centre for Research in Infectious Diseases at Laval University in Quebec City.

TSO3 receives purchase orders for its STERIZONE® sterilization system - Begins shipment of STERIZONE® VP4 Sterilizers to USA

News - TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, announced that the Company has received purchase orders for multiple devices from the US. The orders are the result of the collaborative relationship between Getinge Infection Control, its sales and service provider, and the Company.

Opsens receives Health Canada approval to commercialize its FFR products

News - Opsens Inc. announced it has received Health Canada's approval to commercialize the OptoWire and OptoMonitor, its products developed to measure Fractional Flow Reserve ("FFR"). FFR is used to optimize the diagnosis and guide the treatment of patients with coronary heart disease.

Aeterna Zentaris and EMD Serono Finalize Promotional Services Agreement for Saizen® (Somatropin (rDNA origin) for Injection) in the U.S.

News - Aeterna Zentaris Inc. and EMD Serono, Inc., the U.S. and Canadian biopharmaceutical businesses of Merck KGaA, Darmstadt, Germany, today announced the finalization of a promotional services agreement that will allow Aeterna Zentaris to promote Saizen® [somatropin (rDNA origin) for injection] to designated medical professionals in specified territories in the United States. Saizen® is a recombinant human Growth Hormone (r-hGH) registered in the U.S. for the treatment of growth hormone deficiency (GHD) in children and adults.

Medicago to build $245 M production facility in Quebec City

News - Medicago, a major Canadian biotech company and an international leader in the development and production of plant-based vaccines and therapeutics, is proud to announce that Quebec City will be home to its new production complex. The $245 million project will create 200 new high-skilled jobs by 2019, adding to the team of 180 employees already working at Medicago’s Quebec City office and laboratories. The project is expected to generate more than $461 million in direct and indirect economic benefits over the next five years.

Contacts

Jean-MichelGarroLife Sciences

More details

Newsletter

Subscribe to our newsletter for interesting news and information.

Print this page